Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536984) titled 'Examination of Personalized SpO2 Targets' on April 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Vanderbilt University Medical Center

Condition: Acute Respiratory Failure

Intervention: Other: Personalized SpO2 Target

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: May 2026

Target Sample Size: 3000

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07536984

Published by HT Digital Content Services ...